# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Breast Cancer

Cancer, Breast
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 21-30 of 2380 results.
A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer
Status: Recruiting
Last Changed: Apr 28, 2020
First Received: Dec 21, 2016
Disease(s): Breast Cancer
Intervention(s): Pembrolizumab, Nab-Paclitaxel, Biopsy
Locations: Dana-Farber Cancer Institute, Boston, Massachusetts, United States
A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant Therapy
Status: Recruiting
Last Changed: Jun 04, 2020
First Received: Mar 22, 2018
Disease(s): Metastatic Breast Cancer, Breast Cancer
Intervention(s): Entinostat, Capecitabine
Locations: University of Rochester Medical Center, Rochester, New York, United States
University of Virginia, Charlottesville, Virginia, United States
Pyrotinib Plus Fulvestrant in Patients With HR+/HER2+ Metastatic Breast Cancer (Pyrotinib+Fulvestrant )
Status: Recruiting
Last Changed: Jul 25, 2019
First Received: Jul 25, 2019
Disease(s): Breast Cancer, HER2-positive Breast Cancer
Intervention(s): Pyrotinib Plus Fulvestrant
Locations: Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer
Status: Recruiting
Last Changed: Apr 08, 2019
First Received: Apr 08, 2019
Disease(s): Breast Cancer
Intervention(s): Endostar, Chemotherapy
Locations: Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Prospective and Retrospective Breast Cancer Database
Status: Recruiting
Last Changed: Aug 31, 2016
First Received: Aug 31, 2016
Disease(s): Breast Cancer
Intervention(s): clinical biological database collection
Locations: Institut claudius regaud IUCT ONCOPOLE, Toulouse, France
ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer
Status: Recruiting
Last Changed: May 29, 2020
First Received: Jul 16, 2018
Disease(s): Breast Cancer
Intervention(s): T-DM1
Locations: City of Hope Comprehensive Cancer Center, Duarte, California, United States
The Stamford Hospital, Stamford, Connecticut, United States
Eastern Maine Medical Center, Brewer, Maine, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
... and 11 other locations.
NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer
Status: Recruiting
Last Changed: Apr 28, 2020
First Received: Dec 28, 2018
Disease(s): Breast Cancer
Intervention(s): Nivolumab, Ipilimumab
Locations: Dana-Farber Cancer Institute, Boston, Massachusetts, United States
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Paclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast Cancer
Status: Not yet recruiting
Last Changed: May 22, 2019
First Received: May 22, 2019
Disease(s): Breast Cancer Stage
Intervention(s): nab-paclitaxel
Locations: the first hospital of Jilin University, Jilin, Changchun, China
Transcutaneous Breast Cancer Diagnosis by Canine Odorology
Status: Recruiting
Last Changed: Apr 30, 2020
First Received: Jan 03, 2020
Disease(s): Breast Cancer
Intervention(s): Odour sampling
Locations: Institut de Cancérologie de l'Ouest, Nantes, France
Centre d'imagerie 114, Paris, France
Groupe Hospitalier Paris Saint- Joseph, Paris, France
Institut Curie, Paris, France
Institut Curie, Saint-Cloud, France
... and 2 other locations.
Hypofractionated PBI After BCS for Low-risk Breast Cancer Patients
Status: Recruiting
Last Changed: Feb 04, 2019
First Received: Jan 26, 2018
Disease(s): Breast Cancer
Intervention(s): hypofractionated partial breast irradiation
Locations: Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China